SLC30A6 and prostate carcinoma: However, it is unclear how the downregulation of ZnT5 or ZnT6 could promote prostate cancer; a potential mechanism could be controlling zinc signaling by increasing cytosolic zinc levels, as described for the downregulation of ZnT6 in acute myeloid leukemia [165].